Epilepsy & Seizures

Filter Your Results




Deep Brain Stimulator for Medically-Refractory Epilepsy Now Available in US

Wednesday, February 20, 2019—Deep brain stimulation (DBS) with the Medtronic DBS System (Medtronic, Dublin, Ireland) was approved by the Food and Drug Administration (FDA) last year and is now available i…

New CPT Code for Electrocorticography From Responsive Neurostimulator

Wednesday, February 13, 2019—The American Medical Association (AMA) has issued a new Category/Current Procedural Terminology (CPT) code for electrocorticography from an implanted brain neurostimulato…

Durable Benefit from Treating Batten’s Disease with Cerliponase Alfa

Monday, February 11, 2019—In an ongoing, open-label extension study of cerliponase alfa (Brineura; BioMarin, San Rafael, CA) for treatment of patients with late infantile neuronal ceroid lipofuscinosis…

New Drug Application for Cenobamate to Treat Epilepsy Accepted

Friday, February 08, 2019—The Food and Drug Administration (FDA) has accepted the new drug application (NDA) filing for cenobamate (SK life science; Fair Lawn, NJ), an investigational antiepileptic dru…

New Drug Application Submitted for Low-Dose Fenfluramine for Treatment of Dravet Syndrome

Wednesday, February 06, 2019—A new drug application (NDA) has been submitted to the Food and Drug Administration (FDA) for low-dose fenfluramine (Fintepla, previously known as ZX008; Zogenix, Emeryville, …

Epilepsy Foundation Awards $300,000 in Grants Supporting Novel Treatment Approaches

Wednesday, January 23, 2019—As part of their Epilepsy Therapy Project, the goal of which is to advance innovation in epilepsy and seizure treatment in a timely manner, The Epilepsy Foundation has awarded…

FDA Approves Generic Vigabatrin for Complex Partial Seizures

Monday, January 21, 2019—January 21, 2019 -- The Food and Drug Administration (FDA) has approved generic vigabatrin 500 mg tablets for adjunctive treatment of patients with complex partial seizures, a…

FDA Clears First-in-Class NonEEG, Seizure-Monitoring, Wearable Device for Children

Tuesday, January 08, 2019—The Food and Drug Administration (FDA) has granted 510(k) clearance for a wearable smartband device (Embrace; Empatica, Boston, MA) to detect seizure activity in children age …


Contact Info

For advertising rates and opportunities:
Wendy Terry

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.